Use of the magnetic sphincter augmentation (MSA) device for the laparoscopic treatment of gastroesophageal reflux disease is increasing since the first clinical implant performed a decade ago. The MSA procedure is a minimally invasive and highly standardized surgical option for patients who are partially responders to proton-pump inhibitors, which have troublesome regurgitation or develop progressive symptoms despite continuous medical therapy. The procedure has proven to be highly effective in improving typical reflux symptoms, reducing the use of proton-pump inhibitors, and decreasing esophageal acid exposure. Observational cohort studies have shown that MSA compares well with fundoplication in selected patients and has an acceptable safety profile. The device can be easily removed if necessary, thereby preserving the option of fundoplication in the future. The majority of the removals have occurred within 2 years after implant and have been managed non-emergently, with no complications or long-term consequences. “Expanded” indications to MSA (large hiatal hernia and Barrett’s esophagus) need to be tested in further comparative studies with classic fundoplication procedures.
Magnetic sphincter augmentation for gastroesophageal reflux disease: review of clinical studies / E. Asti, A. Aiolfi, V. Lazzari, A. Sironi, M. Porta, L. Bonavina. - In: UPDATES IN SURGERY. - ISSN 2038-131X. - 70:3(2018 Sep 01), pp. 323-330. [10.1007/s13304-018-0569-6]
Magnetic sphincter augmentation for gastroesophageal reflux disease: review of clinical studies
E. AstiPrimo
;A. AiolfiSecondo
;V. Lazzari;A. Sironi;M. PortaPenultimo
;L. Bonavina
Ultimo
2018
Abstract
Use of the magnetic sphincter augmentation (MSA) device for the laparoscopic treatment of gastroesophageal reflux disease is increasing since the first clinical implant performed a decade ago. The MSA procedure is a minimally invasive and highly standardized surgical option for patients who are partially responders to proton-pump inhibitors, which have troublesome regurgitation or develop progressive symptoms despite continuous medical therapy. The procedure has proven to be highly effective in improving typical reflux symptoms, reducing the use of proton-pump inhibitors, and decreasing esophageal acid exposure. Observational cohort studies have shown that MSA compares well with fundoplication in selected patients and has an acceptable safety profile. The device can be easily removed if necessary, thereby preserving the option of fundoplication in the future. The majority of the removals have occurred within 2 years after implant and have been managed non-emergently, with no complications or long-term consequences. “Expanded” indications to MSA (large hiatal hernia and Barrett’s esophagus) need to be tested in further comparative studies with classic fundoplication procedures.File | Dimensione | Formato | |
---|---|---|---|
Asti2018_Article_MagneticSphincterAugmentationF.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
909.24 kB
Formato
Adobe PDF
|
909.24 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.